# PrizValve® Transcatheter Aortic Valve Replacement Study

Study · id `cardio:ct-nct04836897` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04836897](<https://clinicaltrials.gov/study/NCT04836897>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04836897

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04836897. Allocation not applicable; no masking; primary purpose treatment. Start 2021-01-19 (actual); primary completion 2023-06-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04836897, source copy `cardio:ctgov-nct04836897-2023-11-15`, retrieved 2026-10-26)
- Started: 2021-01-19 (actual) (ClinicalTrials.gov record NCT04836897, source copy `cardio:ctgov-nct04836897-2023-11-15`, retrieved 2026-10-26)
- Primary completion: 2023-06-19 (actual) (ClinicalTrials.gov record NCT04836897, source copy `cardio:ctgov-nct04836897-2023-11-15`, retrieved 2026-10-26)
- Completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT04836897, source copy `cardio:ctgov-nct04836897-2023-11-15`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04836897, source copy `cardio:ctgov-nct04836897-2023-11-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04836897-2023-11-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: PrizValve® Transcatheter Aortic Valve Replacement Study
- Condition: Aortic Valve Stenosis
- Intervention (Device): PrizValve® valve and transapical delivery system
- Lead sponsor: Shanghai NewMed Medical Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Shanghai NewMed Medical Co., Ltd. (`cardio:org-shanghai-newmed-medical-co-ltd`)

## Provenance

Content hash: 049752905b73c723e1770e498c965d1bd0bca5538cd237abed499423522a8807
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
